文献速递炎症性肠病

溃疡性结肠炎患者肠道细菌O-GlcNAcase基因丰度降低,补充该酶可改善小鼠结肠炎

Bacterial O-GlcNAcase genes abundance decreases in ulcerative colitis patients and its administration ameliorates colitis in mice.
PubMed 文献 · Gut · 2020-12-12

本研究分析细菌O-GlcNAcase(OGA)和O-GlcNAc转移酶(OGT)的结构与分布,对1999份宏基因组样本进行汇总分析,发现细菌OGA基因在健康人肠道中丰度高且保守,仅在溃疡性结肠炎中降低。体外和体内实验表明,细菌OGA可水解宿主细胞中O-GlcNAcylated蛋白(包括NF-κB-p65),保护小鼠免受化学诱导的结肠炎症。

要点

  • 细菌OGA基因在健康人肠道中高丰度且保守,仅在溃疡性结肠炎中显著降低。
  • 细菌OGA可水解宿主O-GlcNAcylated蛋白及NF-κB-p65,抑制NF-κB信号。
  • 肠道细菌来源OGA可保护小鼠免受化学诱导的结肠炎症。

核心结论

  • 肠道菌群编码的OGA酶可影响肠道生理,细菌OGA是结肠炎症的潜在治疗策略。

研究设计与样本

  • 先分析细菌OGA和OGT的结构与分类分布,再对1999份宏基因组样本进行汇总分析,最后用体外和体内实验验证细菌OGA的作用与机制。

主要发现

  • OGA而非OGT富集于拟杆菌门和厚壁菌门,多数细菌OGA为分泌酶且具有与人OGA相同的保守催化结构域。
  • 对涵盖六种疾病的1999份宏基因组样本汇总分析显示,细菌OGA基因在健康人肠道中保守且高丰度,仅在溃疡性结肠炎中降低。
  • 体外实验显示细菌OGA可水解宿主细胞中O-GlcNAcylated蛋白,包括O-GlcNAcylated NF-κB-p65亚基。
  • 体内实验显示肠道细菌来源OGA通过水解O-GlcNAcylated蛋白保护小鼠免受化学诱导的结肠炎症。

临床怎么用

  • 细菌OGA可能作为溃疡性结肠炎治疗的新靶点,但尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: O-linked N-acetylglucosaminylation (O-GlcNAcylation), controlled by O-GlcNAcase (OGA) and O-GlcNAc transferase (OGT), is an important post-translational modification of eukaryotic proteins and plays an essential role in regulating gut inflammation. Gut microbiota encode various enzymes involved in O-GlcNAcylation. However, the characteristics, abundance and function of these enzymes are unknown. DESIGN: We first investigated the structure and taxonomic distribution of bacterial OGAs and OGTs. Then, we performed metagenomic analysis to explore the OGA genes abundance in health samples and different diseases. Finally, we employed in vitro and in vivo experiments to determine the effects and mechanisms of bacterial OGAs to hydrolyse O-GlcNAcylated proteins in host cells and suppress inflammatory response in the gut. RESULTS: We found OGAs, instead of OGTs, are enriched in Bacteroidetes and Firmicutes, the major bacterial divisions in the human gut. Most bacterial OGAs are secreted enzymes with the same conserved catalytic domain as human OGAs. A pooled analysis on 1999 metagenomic samples encompassed six diseases revealed that bacterial OGA genes were conserved in healthy human gut with high abundance, and reduced exclusively in ulcerative colitis. In vitro studies showed that bacterial OGAs could hydrolyse O-GlcNAcylated proteins in host cells, including O-GlcNAcylated NF-κB-p65 subunit, which is important for activating NF-κB signalling. In vivo studies demonstrated that gut bacteria-derived OGAs could protect mice from chemically induced colonic inflammation through hydrolysing O-GlcNAcylated proteins. CONCLUSION: Our results reveal a previously unrecognised enzymatic activity by which gut microbiota influence intestinal physiology and highlight bacterial OGAs as a promising therapeutic strategy in colonic inflammation.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. He X, Gao J, Peng L, et al. Bacterial O-GlcNAcase genes abundance decreases in ulcerative colitis patients and its administration ameliorates colitis in mice. Gut. 2020. PMID: 33310751. doi:10.1136/gutjnl-2020-322468

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。